A Comparison of Temperature Measurement During Living Donor Liver Transplantation

August 9, 2021 updated by: Hee-Soo Kim, Seoul National University Hospital

A Comparison of Body Temperature Measured From the Cuff Surface of the Endotracheal Tube and Core Temperature in Living Donor Liver Transplantation

The purpose of this study is to compare the temperature measured from the cuff surface of the endotracheal tube and core temperature measured at the esophagus in living donor liver transplantation recipients.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

Hypothermia occurs frequently in patients undergoing surgery and is known to be related with many postoperative complications. Patients undergoing living donor liver transplantation are usually monitored using an esophageal stethoscope. However, because patients with liver cirrhosis have the risk of variceal bleeding, placement of an esophageal stethoscope can increase the risk of bleeding.

There have been previous reports that temperature monitoring at the cuff surface of an endotracheal tube is not only safe but also provides accurate and reliable data during mild hypothermia after cardiac arrest.

This study compares the temperature measured from the cuff surface of the endotracheal tube and core temperature measured at the esophagus and additionally core temperature measured by a pulmonary artery catheter. The study participants are intubated with an endotracheal tube that has a temperature sensor at the cuff surface of the tube. The rest of the procedure is done according to Seoul National University Hospital's protocol for liver transplantation: an esophageal stethoscope is placed for temperature monitoring and a central line is placed with a Multi-Access lumen Catheter and a pulmonary artery catheter is placed. The temperature measurements from the endotracheal tube and measurements from the esophageal stethoscope are compared at the following 5 phases: 1. preanhepatic phase, 2. anhepatic phase 1 (recipient hepatectomy - IVC clamping), 3. anhepatic phase 2 (IVC clamping - reperfusion), 4. Reperfusion phase, 5. Neohepatic phase.

Study Type

Interventional

Enrollment (Anticipated)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • routine living donor liver transplantation recipients needing pulmonary artery catheterization who have been informed and given consent

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Tracheal Temperature
Intubation done with a temperature sensor located on the cuff surface of the endotracheal tube
Temperature measured from the endotracheal tube compared with the esophageal temperature

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of temperature from the cuff surface of the endotracheal tube and esophageal temperature
Time Frame: Phase 1 (preanhepatic): 60 minutes after the anesthetic induction
temperature
Phase 1 (preanhepatic): 60 minutes after the anesthetic induction
Comparison of temperature from the cuff surface of the endotracheal tube and esophageal temperature
Time Frame: Phase 2 (anhepatic 1): 10 minutes after recipient hepatectomy
temperature
Phase 2 (anhepatic 1): 10 minutes after recipient hepatectomy
Comparison of temperature from the cuff surface of the endotracheal tube and esophageal temperature
Time Frame: Phase 3 (anhepatic 2): 10 minutes after IVC clamping
temperature
Phase 3 (anhepatic 2): 10 minutes after IVC clamping
Comparison of temperature from the cuff surface of the endotracheal tube and esophageal temperature
Time Frame: Phase 4 (Reperfusion): 5 minutes after Reperfusion
temperature
Phase 4 (Reperfusion): 5 minutes after Reperfusion
Comparison of temperature from the cuff surface of the endotracheal tube and esophageal temperature
Time Frame: Phase 5 (neohepatic): 1 hour after Reperfusion
temperature
Phase 5 (neohepatic): 1 hour after Reperfusion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of temperature from the cuff surface of the endotracheal tube and temperature measured at the pulmonary artery catheter
Time Frame: Phase 1 (preanhepatic): 60 minutes after the anesthetic induction
temperature
Phase 1 (preanhepatic): 60 minutes after the anesthetic induction
Comparison of temperature from the cuff surface of the endotracheal tube and temperature measured at the pulmonary artery catheter
Time Frame: Phase 2 (anhepatic 1): 10 minutes after recipient hepatectomy
temperature
Phase 2 (anhepatic 1): 10 minutes after recipient hepatectomy
Comparison of temperature from the cuff surface of the endotracheal tube and temperature measured at the pulmonary artery catheter
Time Frame: Phase 3 (anhepatic 2): 10 minutes after IVC clamping
temperature
Phase 3 (anhepatic 2): 10 minutes after IVC clamping
Comparison of temperature from the cuff surface of the endotracheal tube and temperature measured at the pulmonary artery catheter
Time Frame: Phase 4 (Reperfusion): 5 minutes after Reperfusion
temperature
Phase 4 (Reperfusion): 5 minutes after Reperfusion
Comparison of temperature from the cuff surface of the endotracheal tube and temperature measured at the pulmonary artery catheter
Time Frame: Phase 5 (neohepatic): 1 hour after Reperfusion
temperature
Phase 5 (neohepatic): 1 hour after Reperfusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

August 13, 2021

Primary Completion (Anticipated)

June 30, 2022

Study Completion (Anticipated)

June 30, 2022

Study Registration Dates

First Submitted

June 23, 2021

First Submitted That Met QC Criteria

June 23, 2021

First Posted (Actual)

June 29, 2021

Study Record Updates

Last Update Posted (Actual)

August 10, 2021

Last Update Submitted That Met QC Criteria

August 9, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 20210623

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Living Donor Liver Transplantation

Clinical Trials on Tracheal Temperature

Subscribe